Seller record · Telehealth service

NoBsRx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published. The pricing, answers and about pages say every ingredient its partner pharmacies use comes with a certificate of analysis, with no document behind the claim. 1 more criterion also fails; see the table below.

At a glance

NoBsRxTelehealth service

5/8criteria passed

Price: Semaglutide injection $149 a month, tirzepatide $225
Sells: compounded semaglutide injection, oral semaglutide, and 2 more
FDA letters: None on file

Visit NoBsRx See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A GLP-1 access platform selling compounded semaglutide as an injection or tablets and compounded tirzepatide at published monthly prices, including low-dose plans, through independent licensed providers. Care starts with an online intake, and the terms name four dispensing pharmacies.

Operating entity No legal entity name appears in the footer, on the contact page, in the terms or in the privacy policy, whose contact blocks give only the brand name.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	NoBsRx's how it works page; NoBsRx's terms
S2	Prescription gating	NOT VERIFIED	NoBsRx's refund policy; NoBsRx's how it works page
S3	Pharmacy identification	PASS	NoBsRx's terms
S4	Compounding disclosure	PASS	NoBsRx's disclosures page; NoBsRx's GLP-1 education page
S5	Analytical documentation	FAIL	NoBsRx's pricing page; NoBsRx's FAQ; NoBsRx's about page
S6	Business address	FAIL	NoBsRx's contact page; NoBsRx's terms; NoBsRx's privacy page
S7	Price disclosure	PASS	NoBsRx's pricing page; NoBsRx's terms; NoBsRx's subscription terms
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider independently reviews each intake and decides whether treatment is appropriate, and the terms say eligibility, treatment decisions and prescriptions are made only by independent licensed providers.Source: NoBsRx's how it works page; NoBsRx's terms.

S2NOT VERIFIEDThe order path behind the start buttons did not resolve, because they lead to a partner intake that was not opened, while the refund policy describes a platform fee paid before the intake is submitted and the process page lists the intake and a provider review with no payment step. The check is open.Source: NoBsRx's refund policy; NoBsRx's how it works page.

S3PASSThe terms name four pharmacies that may dispense and ship medication, each with a street address and telephone number: Red Rock Compounding Pharmacy in St. George, Utah, Health Warehouse in Florence, Kentucky, Precision Medicine in Bellmore, New York, and Triad Rx in Daphne, Alabama.Source: NoBsRx's terms.

S4PASSThe disclosures page states that compounded medications are not FDA-approved, and the GLP-1 education page says the compounded semaglutide and tirzepatide it offers are not FDA-approved.Source: NoBsRx's disclosures page; NoBsRx's GLP-1 education page.

S5FAILNo certificate of analysis or lot document is published. The pricing, answers and about pages say every ingredient its partner pharmacies use comes with a certificate of analysis, with no document behind the claim.Source: NoBsRx's pricing page; NoBsRx's FAQ; NoBsRx's about page.

S6FAILNo address for the business is printed on the contact page, in the footer, in the terms or in the privacy policy. The only street addresses on the site belong to the pharmacies listed in the terms.Source: NoBsRx's contact page; NoBsRx's terms; NoBsRx's privacy page.

S7PASSSemaglutide injection at $149 a month, oral semaglutide at $174 and tirzepatide injection at $225, or prepaid for 12, 24 or 52 weeks (semaglutide injection at $390, $790 or $1,551). Low-dose semaglutide injection or tablets and low-dose tirzepatide at $115 a month or $340 for 12 weeks. The pricing page calls each figure the ongoing program price at every dose, and a code takes $20 off the first order through October. The terms say pharmacy, medication and shipping fees are payable to the pharmacies and are not included in the platform subscription.Source: NoBsRx's pricing page; NoBsRx's terms; NoBsRx's subscription terms.

S8PASSNo FDA warning letter names NoBsRx, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, oral semaglutide, compounded tirzepatide injection, low-dose semaglutide and tirzepatide programs.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit NoBsRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.